Hyderabad-based Bharat Biotech will make a presentation before the Subject Expert Committee of the Central Drug Standard Control Organisation (CDSCO) on Wednesday evening for approval of its vaccine - Covaxin, government sources told IANS.

Earlier on Wednesday, the Serum Institute of India (SII)'s application for emergency use authorisation of its Covid-19 vaccine was also considered by the Subject Expert Committee.